BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9553721)

  • 21. Development of a new easy complementation assay for DNA repair deficient human syndromes using cloned repair genes.
    Carreau M; Eveno E; Quilliet X; Chevalier-Lagente O; Benoit A; Tanganelli B; Stefanini M; Vermeulen W; Hoeijmakers JH; Sarasin A
    Carcinogenesis; 1995 May; 16(5):1003-9. PubMed ID: 7767957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus.
    Armelini MG; Muotri AR; Marchetto MC; de Lima-Bessa KM; Sarasin A; Menck CF
    Cancer Gene Ther; 2005 Apr; 12(4):389-96. PubMed ID: 15650764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cockayne syndrome and xeroderma pigmentosum.
    Rapin I; Lindenbaum Y; Dickson DW; Kraemer KH; Robbins JH
    Neurology; 2000 Nov; 55(10):1442-9. PubMed ID: 11185579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for persistent UV-induced DNA damage and altered DNA damage response in xeroderma pigmentosa patient corneas.
    Akepogu J; Jakati S; Chaurasia S; Ramachandran C
    Exp Eye Res; 2024 Jun; 243():109901. PubMed ID: 38641197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding Xeroderma Pigmentosum Complementation Groups Using Gene Expression Profiling after UV-Light Exposure.
    Bowden NA; Beveridge NJ; Ashton KA; Baines KJ; Scott RJ
    Int J Mol Sci; 2015 Jul; 16(7):15985-96. PubMed ID: 26184184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xeroderma pigmentosum--bridging a gap between clinic and laboratory.
    Moriwaki S; Kraemer KH
    Photodermatol Photoimmunol Photomed; 2001 Apr; 17(2):47-54. PubMed ID: 11338401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease.
    Dupuy A; Sarasin A
    Mutat Res; 2015 Jun; 776():2-8. PubMed ID: 26255934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of a recombinant adenovirus containing the denV gene from bacteriophage T4 which can partially restore the DNA repair deficiency in xeroderma pigmentosum fibroblasts.
    Colicos MA; Haj-Ahmad Y; Valerie K; Henderson EE; Rainbow AJ
    Carcinogenesis; 1991 Feb; 12(2):249-55. PubMed ID: 1704821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Requirement for functional DNA polymerase eta in genome-wide repair of UV-induced DNA damage during S phase.
    Auclair Y; Rouget R; Belisle JM; Costantino S; Drobetsky EA
    DNA Repair (Amst); 2010 Jul; 9(7):754-64. PubMed ID: 20457011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.
    Oh KS; Khan SG; Jaspers NG; Raams A; Ueda T; Lehmann A; Friedmann PS; Emmert S; Gratchev A; Lachlan K; Lucassan A; Baker CC; Kraemer KH
    Hum Mutat; 2006 Nov; 27(11):1092-103. PubMed ID: 16947863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel XPG (ERCC5) mutations affect DNA repair and cell survival after ultraviolet but not oxidative stress.
    Soltys DT; Rocha CR; Lerner LK; de Souza TA; Munford V; Cabral F; Nardo T; Stefanini M; Sarasin A; Cabral-Neto JB; Menck CF
    Hum Mutat; 2013 Mar; 34(3):481-9. PubMed ID: 23255472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum.
    Brooks PJ
    Neuroscience; 2007 Apr; 145(4):1407-17. PubMed ID: 17184928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential behaviors toward ultraviolet A and B radiation of fibroblasts and keratinocytes from normal and DNA-repair-deficient patients.
    Otto AI; Riou L; Marionnet C; Mori T; Sarasin A; Magnaldo T
    Cancer Res; 1999 Mar; 59(6):1212-8. PubMed ID: 10096550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer.
    van Steeg H; Kraemer KH
    Mol Med Today; 1999 Feb; 5(2):86-94. PubMed ID: 10200950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
    Nishigori C; Fujisawa H; Uyeno K; Kawaguchi T; Takebe H
    Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):146-50. PubMed ID: 1814424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sunlight, Vitamin D, and Xeroderma Pigmentosum.
    Martens MC; Emmert S; Boeckmann L
    Adv Exp Med Biol; 2020; 1268():319-331. PubMed ID: 32918226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Xeroderma pigmentosum variant with multisystem involvement.
    Hessel A; Siegle RJ; Mitchell DL; Cleaver JE
    Arch Dermatol; 1992 Sep; 128(9):1233-7. PubMed ID: 1519938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of UV-induced apoptosis by the human DNA repair protein XPG.
    Clément V; Dunand-Sauthier I; Clarkson SG
    Cell Death Differ; 2006 Mar; 13(3):478-88. PubMed ID: 16167068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA repair defect in xeroderma pigmentosum group C and complementing factor from HeLa cells.
    Shivji MK; Eker AP; Wood RD
    J Biol Chem; 1994 Sep; 269(36):22749-57. PubMed ID: 8077226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UV-enhanced reactivation of a UV-damaged reporter gene suggests transcription-coupled repair is UV-inducible in human cells.
    Francis MA; Rainbow AJ
    Carcinogenesis; 1999 Jan; 20(1):19-26. PubMed ID: 9934845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.